C12N 2830/704
S. cerevisiae
C12N2830/704 (S. cerevisiae) appears on 21 US grants and 3 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 3
- Assignees
- 11
- Inventors
- 40
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 2 | 0 |
| 2008 | 2 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Recombinant expression vector for high expression of brazzein in Saccharomyces cerevisiae and method for mass-production of brazzein using the same9 Jun 2026US 12,649,768 B2Chung Ang University Industry Academic Cooperation Foundation
- Recombinant expression vector for high expression of brazzein in Saccharomyces cerevisiae and method for mass-production of brazzein using the same6 Aug 2024US 12,054,524 B2Chung Ang University Industry Academic Cooperation Foundation
- Screening method for compounds that reduce ER stress7 Aug 2012US 8,236,490 B2EM Biotecnologia S.A.
- Purified pol DNA, a recombinant DNA construct for expression of HIV pol polypeptide sequences and a cell containing such construct5 May 2009US 7,527,925 B1Novartis Vaccines and Diagnostics, Inc.
- Recombinant DNA construct for HIV envelope polypeptides and polypeptides produced thereby16 Sep 2008US 7,425,428 B1Novartis Vaccines and Diagnostics, Inc.
- Recombinant expression vector for high expression of brazzein in saccharomyces cerevisiae and method for mass-production of brazzein using the same24 Oct 2024US 2024/0352078 A1Chung Ang University Industry Academic Cooperation Foundation
- Recombinant expression vector for high expression of brazzein in saccharomyces cerevisiae and method for mass-production of brazzein using the same15 Sep 2022US 2022/0289799 A1Chung Ang University Industry Academic Cooperation Foundation
- Screening method for compounds that reduce er stress26 Aug 2010US 2010/0215641 A1Bioalvo-Servicos, Investigacao e Desenvolvirmento em Biotecnologis S.A.
Most cited
By later US patents
- Methods of transcriptionally modulating expression of viral genes and genes useful for production of proteins115US 6,165,712 AOSI Pharmaceuticals, Inc. · 2000
- Immunoassays for antibody to human immunodeficiency virus using recombinant antigens81US 5,156,949 AChiron Corporation · 1992
- Fibrinolytic and anti-thrombotic cleavable dimers27US 5,434,073 ABritish Bio-Technology Limited · 1995
- Vector for expression of a polypeptide in a mammalian cell27US 5,688,688 AChiron Corporation · 1997
- Use of interleukin-7 to stimulate proliferation of hematopoietic cell precursors18US 5,705,149 ASterling Winthrop Inc. · 1998